Assessment of Serum Leptin Levels in Females With Papillary Thyroid Carcinoma, Benign Thyroid Nodules, and Normal Controls
19 Years
75 Years
Female
Thyroid Cancer, Papillary, Leptin Levels
Trial Information
Assessment of Serum Leptin Levels in Females With Papillary Thyroid Carcinoma, Benign Thyroid Nodules, and Normal Controls
There will be three groups in this study, but 2 of the groups are part of another study so
will only recruit normal controls.
Inclusion Criteria:
- Female
- Age>/- 19
- Not currently pregnant or lactating
- Normal thyroid gland by history
Exclusion Criteria:
- Male Gender
- Pregnancy
- Lactation
- Age below 19
- Abnormal thyroid gland by history
- Abnormal thyroid gland by structure using ultrasound
- Abnormal thyroid gland by function using TSH, Free T4
Type of Study:
Observational
Study Design:
Time Perspective: Cross-Sectional
Outcome Measure:
evaluating Leptin level Evaluating Serum Leptin Levels Between 3 Groups. One Group with Papillary Thyroid Carcinoma. One Group With Benign Nodules. One Group with Normal Thyroid.
Outcome Description:
Assessing serum leptin levels in females with treated papillary thyroid carcinoma and compared to females with proven benign thyroid nodules and females with normal thyroid glands. All groups were matched by gender, age, and BMI to limit confounders.
Outcome Time Frame:
During Study
Safety Issue:
No
Principal Investigator
Whitney Goldner, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Nebraska
Authority:
United States: Institutional Review Board
Study ID:
276-12-EP
NCT ID:
NCT01659385
Start Date:
August 2012
Completion Date:
June 2013
Related Keywords:
- Thyroid Cancer, Papillary
- Leptin Levels
- Thyroid Neoplasms
- Thyroid Diseases
Name | Location |
|---|---|
| University of Nebraska Medical Center | Omaha, Nebraska 68198-3330 |
